Overall n=144 TOL group n=84 PCS group n=60
p value
OR (95% CI)
aOR (95% CI)**
Composite perinatal morbidity, n(%) 8 (5.6) 3 (3.6) 5 (8.3) 0.22 2.46 (0.56-10.69) 1.36 (0.24-7.81)
First twin 4 (5.6) 2 (4.8) 2 (3.3) 0.73 1.43 (0.19-10.75) 0.77 (0.074-8.04)
Second twin 4 (5.6) 1 (2.4) 3 (5) 0.16 4.56 (0.45-46.11) 3.20 (0.16-65.88)
> 34 week’s 4/124 (3.2) 2/80 (2.5) 2/44 (4.5) 0.54 1.86 (0.25-13.66) 4.69 (0.85-25.81)
> 36 week’s 3/86 (3.5) 1/56 (1.8) 2/30 (6.7) 0.24 3.93 (0.34-45.22) 5.21 (0.49-55.63)
5-minute Apgar score <4 0 0 0 - * *
5-minute Apgar score <7 1 (0.7) 1 (1.2) 0 >0.99 * *
Neonatal death 0 0 0 - * *
Respiratory morbidity (respiratory distress síndrome and/or bronchopulmonary dysplasia) 0 0 0 - * *
Intraventricular hemorrhage 5 (3.5) 2 (2.4) 3 (5.0) 0.40 2.16 (0.35-13.33) 1.64 (0.19-14.57)
Periventricular leukomalacia 1 (0.7) 0 1 (1.7) 0.42 * *
Necrotizing enterocolitis 1 (0.7) 0 1 (1.7) 0.42 * *
Sepsis 0 0 0 - * *
2-year-Neurodevelopmental impairment, n(%) 10/140 (7.1) 4/81 (4.9) 6 / 59 (10.2) 0.26 2.11 (0.57-7.84) 1.53 (0.37-6.29)
Severe neurodevelopmental impairment 2/140 (1.4) 0 2 / 59 (3.4) 0.18 * *